ASSESSMENT OF UNEXPLAINED CARDIOMYOPATHY: CLINICAL UTILITY OF DELAYED-ENHANCEMENT CARDIAC MAGNETIC RESONANCE COMPARED TO ENDOMYOCARDIAL BIOPSY  by Sobol, Irina et al.
Pericardial/Myocardial Disease
E1553
JACC March 27, 2012
Volume 59, Issue 13
ASSESSMENT OF UNEXPLAINED CARDIOMYOPATHY: CLINICAL UTILITY OF DELAYED-ENHANCEMENT 
CARDIAC MAGNETIC RESONANCE COMPARED TO ENDOMYOCARDIAL BIOPSY
ACC Moderated Poster Contributions
McCormick Place South, Hall A
Sunday, March 25, 2012, 9:30 a.m.-10:30 a.m.
Session Title: Pericardial/Myocardial Disease II
Abstract Category: 12. Pericardial/Myocardial Disease
Presentation Number: 1127-207
Authors: Irina Sobol, Evelyn Horn, Abiola Dele-Michael, Fay Lin, Madeline Yushak, Fahmida Islam, Parag Goyal, Jonathan Weinsaft, Weill Cornell 
Medical College, New York City, NY, USA
Background: Delayed enhancement cardiac magnetic resonance (CMR) enables high resolution characterization of myocardium. Our aim was to 
evaluate the diagnostic performance of CMR vs. a reference of endomyocardial biopsy (EMB) in unexplained cardiomyopathy.
Methods: We studied consecutive patients without coronary artery disease who underwent CMR and EMB within 90 days. EMB specimens were 
analyzed for myocardial and vascular pathology. CMR was read blinded to EMB: myocardial scar was scored via a 17-segment model. CMR was 
deemed positive if myocardial hyperenhancement was present, and EMB if diagnostic for cardiomyopathy etiology.
Results: 43 patients were studied (60% male, 48±18yo, LVEF 38±21%), comprising 35% of all patients who underwent EMB between 1/07-
11/2011. Mean interval between EMB and CMR was 15±20 days; 60% underwent both within 7 days. CMR was positive for myocardial scar in 
31 patients (87% focal, 13% diffuse). EMB was diagnostic in 12 patients (amyloid=5, myocarditis=4, sarcoid=2, lymphoma=1). CMR yielded high 
sensitivity (92%) and negative predictive value (93%). Only one patient with negative CMR had positive EMB - it showed vascular amyloid without 
myocardial abnormalities. Over half (18/29) of patients with scar on CMR had negative EMB (specificity =42%, positive predictive value=38%). 
Performance of CMR vs. EMB
Sensitivity Specificity Accuracy Positive Predictive Value Negative Predictive Value
92% (11/12) 42% (13/31) 56% (24/43) 38% (11/29) 93% (13/14)
Conclusion: CMR has high sensitivity and negative predictive value for assessment of EMB-evidenced myocardial pathology, supporting its use as 
a screening tool in unexplained cardiomyopathy
